title: [Which follow-up of the second generation antipsychotic in adolescents?].
abstract: Since the introduction of so called second generation antipsychotic (SGA), the prescription of these drugs has been relatively frequent in adolescence. This article gives a synopsis of the potential side effects and contra-indications, and proposes a practical guideline for the follow-up of these SGAs in adolescent and young adults. The main secondary side effects are in metabolic, endocrine, neurologic, cardiovascular systems and also on the hematological and liver functions. Thus, a strict follow-up should start before the introduction of a SGA treatment and should be continued during the time of administration. Since there is no common consent for a follow-up in SGA use in adolescents for Europe, this article may give a practical guideline for general practitioners and pediatricians, including a clinical exam and biological parameters to be controlled.
authors: Tina
authors: T
authors: Huber-Gieseke
authors: Maria
authors: M
authors: Perin
authors: Françoise
authors: F
authors: Narring
mesh_terms: D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy; D000075202:Contraindications; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008297:Male; D011358:Product Surveillance, Postmarketing / Q000379:methods; D015430:Weight Gain / Q000187:drug effects; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents